HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Search Today's Posts Mark Forums Read

Reply
 
Thread Tools Display Modes
Old 01-01-2012, 01:22 AM   #1
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
metformin may help prevent her2+ breast cancer

http://www.impactjournals.com/oncota...e&op=view&path[]=387

free access
Lani is offline   Reply With Quote
Old 01-01-2012, 01:23 AM   #2
Lani
Senior Member
 
Join Date: Mar 2006
Posts: 4,778
Re: metformin may help prevent her2+ breast cancer

Oncotarget. 2011 Dec 24. [Epub ahead of print]
Metformin: Multi-faceted protection against cancer.
Barco SD, Vazquez-Martin A, CufĂ* S, Oliveras-Ferraros C, Bosch-Barrera J, Joven J, Martin-Castillo B, Menendez JA.
Source
Medical Oncology, Catalan Institute of Oncology, Girona, Catalonia, Spain.
Abstract
The biguanide metformin, a widely used drug for the treatment of type 2 diabetes, may exert cancer chemopreventive effects by suppressing the transformative and hyperproliferative processes that initiate carcinogenesis. Metformin's molecular targets in cancer cells (e.g., mTOR, HER2) are similar to those currently being used for directed cancer therapy. However, metformin is nontoxic and might be extremely useful for enhancing treatment efficacy of mechanism-based and biologically targeted drugs. Here, we first revisit the epidemiological, preclinical, and clinical evidence from the last 5 years showing that metformin is a promising candidate for oncology therapeutics. Second, the anticancer effects of metformin by both direct (insulin-independent) and indirect (insulin-dependent) mechanisms are discussed in terms of metformin-targeted processes and the ontogenesis of cancer stem cells (CSC), including Epithelial-to-Mesenchymal Transition (EMT) and microRNAs-regulated dedifferentiation of CSCs. Finally, we present preliminary evidence that metformin may regulate cellular senescence, an innate safeguard against cellular immortalization. There are two main lines of evidence that suggest that metformin's primary target is the immortalizing step during tumorigenesis. First, metformin activates intracellular DNA damage response checkpoints. Second, metformin attenuates the anti-senescence effects of the ATP-generating glycolytic metabotype-the Warburg effect-, which is required for self-renewal and proliferation of CSCs. If metformin therapy presents an intrinsic barrier against tumorigenesis by lowering the threshold for stress-induced senescence, metformin therapeutic strategies may be pivotal for therapeutic intervention for cancer. Current and future clinical trials will elucidate whether metformin has the potential to be used in preventive and treatment settings as an adjuvant to current cancer therapeutics.
PMID: 22203527 [PubMed - as supplied by publisher] Free full text
Lani is offline   Reply With Quote
Old 01-01-2012, 02:34 PM   #3
Rich66
Senior Member
 
Rich66's Avatar
 
Join Date: Feb 2008
Location: South East Wisconsin
Posts: 3,431
Re: metformin may help prevent her2+ breast cancer

Liked this part also:
Quote:
Metformin and estradiol
Active AMPK inhibits the expression of the aromatase gene in breast adipose tissue by decreasing the local production of estrogen [93]. Furthermore, obese patients with breast cancer exhibit a higher expression of this gene and higher levels of estrogen in breast tissue as a result of increased plasma leptin synthesis, which is caused by obesity. Leptin inhibits AMPK by increasing the expression of aromatase; however, adiponectin activates AMPK. Therefore, metformin-based treatments aimed at activating AMPK and restoring the leptin/adiponectin axis may decrease the occurrence of breast cancer in obese patients.
At this point Metformin appears to simultaneously target mechanisms involved with triple negative, ER+ and Her2+ breast cancer as well as other cancers.


A potent her2 portion of the paper:

Quote:
it is worth mentioning that metformin acts synergistically with the anti-HER2 monoclonal antibody trastuzumab (Herceptin™) to eliminate stem/progenitor cell populations in HER2-gene amplified breast carcinoma cells growing as mammospheres [108]. Moreover, metformin treatment efficiently reverses secondary resistance of HER2-overexpressing cancer cells to the dual HER1/HER2 tyrosine kinase inhibitor lapatinib (Tykerb™) by suppressing pro-survival pathways (i.e., the anti-apoptotic protein survivin) [109-111].
In HER2-positive tumors, metformin has a dual effect: 1) inhibiting the activity/expression of the HER2 onco-tyrosine kinase and 2) blocking the action of mTOR, a possible mechanism of resistance to trastuzumab [88, 112]. Additionally, by decreasing the levels of circulating insulin and IGF, activation of the IGFR pathway will be avoided. Because transactivation of the IGFR pathway is a well-recognized mechanism underlying de novo (i.e., primary) [113] and acquired (i.e., secondary) [114, 115] resistance to anti-HER2 therapies, metformin’s ability to simultaneously target HER2, while preventing increased IGF-IR signaling may represent a potential therapeutic tool in breast carcinomas resistant to HER2-directed therapy. In support of this, a recently conducted pre-clinical study with trastuzumab-sensitive parental breast cancer cell lines (i.e., BT474 and SKBR3) and trastuzumab-resistant breast cancer sublines (i.e., BT-474-HR20 and SKBR3-pool2) showed that metformin treatment causes significantly more inhibition of proliferation and clonogenicity in trastuzumab-resistant sublines via disruption of HER2/IGF-IR complexes (which are solely present in the resistant sublines) [116]. Importantly, this effect occurred without altering HER2 expression or reduction of IGF-IR expression or activity in the trastuzumab-resistant but not in the sensitive breast cancer cells. The activity of AMPK in cardiac cells is associated with stress-induced survival in response to cytokines or energy depletion. Thus, the concurrent blockage of oncogenic receptors such as HER2, while activating AMPK-related catabolic pathways with metformin would be a highly efficacious therapy to prevent, delay and/or reverse resistance to the HER2 inhibitor while decreasing the risk of cardiomyopathy [109, 117].
Rich66 is offline   Reply With Quote
Old 01-02-2012, 02:27 PM   #4
radiant
Senior Member
 
Join Date: Oct 2008
Posts: 88
Re: metformin may help prevent her2+ breast cancer

This ROCKS - thanks Rich and Lani. wowza ;-)

Kim
__________________
------------------------------
Dx Stage 3C 2005, triple +, tons of lymph nodes as well. FEC, surgery, TCH, rads, herceptin 1 year. And, Aromasin.
2007 - recurrence to medistinal lymph node, Abraxene and Herceptin - took it down 50%
2008 - on Arimidex/Herceptin - stable lymph node.
2009 - stable on Arimidex/Herceptin
2010 - lymph node progression and liver mets.
2010 - went on Gemzar, Navelbine, Herceptin - Navelbine and Herceptin took liver mets down. lymph node slightly progressed.
2010 - did Xeloda & Tykerb - MAJOR progression in liver in only 6 weeks.
Dec 2010 - present - Ixempra/Avastin/Herceptin/Fasoldex - regressing
June 2012 - chemo break
Sept 19, 2012 - start t-dm1. Chose this over going back on Ixempra.
radiant is offline   Reply With Quote
Old 01-02-2012, 08:51 PM   #5
AlaskaAngel
Senior Member
 
AlaskaAngel's Avatar
 
Join Date: Sep 2005
Location: Alaska
Posts: 2,018
Re: metformin may help prevent her2+ breast cancer

Even better are those patients who are determined to help with finding any possible ways to make a difference:

http://her2support.org/vbulletin/showthread.php?t=52216


http://her2support.org/vbulletin/showthread.php?t=52215


http://her2support.org/vbulletin/showthread.php?t=52335
__________________
Dx 2002 age 51
bc for granny, aunt, cousin, sister, mother.
ER+/PR+/HER2+++, grade 3
IDC 1.9 cm, some DCIS, Stage 1, Grade 3
Lumpectomy, CAFx6 (no blood boosters), IMRT rads, 1 3/4 yr tamoxifen
Rads necrosis
BRCA 1 & 2 negative
Trials: Early detection OVCA; 2004 low-dose testosterone for bc survivors
Diet: Primarily vegetarian organic; metformin (no diabetes), vitamin D3
Exercise: 7 days a week, 1 hr/day
No trastuzumab, no taxane, no AI
NED
AlaskaAngel is offline   Reply With Quote
Old 01-03-2012, 05:35 AM   #6
sarah
Senior Member
 
Join Date: Sep 2005
Location: france
Posts: 1,648
Re: metformin may help prevent her2+ breast cancer

wow! sounds good. Is this still in trials? in use?
sarah
__________________
sarah is offline   Reply With Quote
Old 01-03-2012, 10:32 AM   #7
Rich66
Senior Member
 
Rich66's Avatar
 
Join Date: Feb 2008
Location: South East Wisconsin
Posts: 3,431
Re: metformin may help prevent her2+ breast cancer

Both. But some non-diabetic cancer patients are getting it "off label" outside of trials.
Rich66 is offline   Reply With Quote
Old 01-03-2012, 11:33 AM   #8
AlaskaAngel
Senior Member
 
AlaskaAngel's Avatar
 
Join Date: Sep 2005
Location: Alaska
Posts: 2,018
Re: metformin may help prevent her2+ breast cancer

For those who are interesting in making progress with the possibility of use of metformin for breast cancer:

http://clinicaltrials.gov/ct2/result...tformin+breast
__________________
Dx 2002 age 51
bc for granny, aunt, cousin, sister, mother.
ER+/PR+/HER2+++, grade 3
IDC 1.9 cm, some DCIS, Stage 1, Grade 3
Lumpectomy, CAFx6 (no blood boosters), IMRT rads, 1 3/4 yr tamoxifen
Rads necrosis
BRCA 1 & 2 negative
Trials: Early detection OVCA; 2004 low-dose testosterone for bc survivors
Diet: Primarily vegetarian organic; metformin (no diabetes), vitamin D3
Exercise: 7 days a week, 1 hr/day
No trastuzumab, no taxane, no AI
NED
AlaskaAngel is offline   Reply With Quote
Old 01-04-2012, 02:53 AM   #9
sarah
Senior Member
 
Join Date: Sep 2005
Location: france
Posts: 1,648
Re: metformin may help prevent her2+ breast cancer

Thanks Rich and Alaska
__________________
sarah is offline   Reply With Quote
Old 01-04-2012, 03:35 PM   #10
karen z
Senior Member
 
Join Date: Apr 2008
Posts: 1,477
Re: metformin may help prevent her2+ breast cancer

Yes, many thanks for all of the postings.
karen z is offline   Reply With Quote
Old 01-05-2012, 08:42 AM   #11
LoisLane
Senior Member
 
LoisLane's Avatar
 
Join Date: Mar 2010
Location: Thornhill Ontario Canada
Posts: 266
Re: metformin may help prevent her2+ breast cancer

I spoke to my oncologist at the recent checkup in November as they do have a Metformin trial on here in Toronto either at Mt. Sinai or Sunnybrook. I printed off the info to take to him as they say to do when you see a trial you are intetrested in. He said I was unable to participate as I am now three years from diagnosis and apparently you have to be one year or less out from surgery, treatment etc. It was the first trial I have seen that I would have qualified for as small tumour, no nodes etc. However I feel so blessed to be three years out and doing well. I hope these trials do show positive outcomes with Metformin. Best wishes to all Lois
__________________
August 2008
Lumpectomy left breast
1 tumour 0.9 cm
Her2 negative
lymph nodes negative
venous/lymphatic invasion absent
ER+PR-
Stage I Grade 2
Radiation and Femara

November 2008
Lumpectomy right breast
2 tumours .03 cm and .05 cm and extensive DCIS
.05 tumour Her2+
lymph node negative
venous/lymphatic invasion "indeterminate"
ER+PR low postive
Stage 1 Grade 2

January 2009
bilateral mastectomy
chemotherapy taxotere
Herceptin one year
Femara
LoisLane is offline   Reply With Quote
Old 01-05-2012, 11:33 AM   #12
Rich66
Senior Member
 
Rich66's Avatar
 
Join Date: Feb 2008
Location: South East Wisconsin
Posts: 3,431
Re: metformin may help prevent her2+ breast cancer

Lois,
Would you or your onc or GP consider off label use?
Rich66 is offline   Reply With Quote
Old 01-05-2012, 09:15 PM   #13
LoisLane
Senior Member
 
LoisLane's Avatar
 
Join Date: Mar 2010
Location: Thornhill Ontario Canada
Posts: 266
Re: metformin may help prevent her2+ breast cancer

Hi Rich thanks for your response. No I dont think there is any way my family doctor or oncologist would prescribe this. I know on breastcancer.org some women there are getting the prescription from family docs. Take care Lois
__________________
August 2008
Lumpectomy left breast
1 tumour 0.9 cm
Her2 negative
lymph nodes negative
venous/lymphatic invasion absent
ER+PR-
Stage I Grade 2
Radiation and Femara

November 2008
Lumpectomy right breast
2 tumours .03 cm and .05 cm and extensive DCIS
.05 tumour Her2+
lymph node negative
venous/lymphatic invasion "indeterminate"
ER+PR low postive
Stage 1 Grade 2

January 2009
bilateral mastectomy
chemotherapy taxotere
Herceptin one year
Femara
LoisLane is offline   Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 01:14 AM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter